References
- EikelisNEslerMThe neurobiology of human obesityExp Physiol2005906738216105936
- GiordanoSHBooserDJMurrayJLA detailed evaluation of cardiac toxicity: a phase II study of doxorubicin and one- or three-hour-infusion paclitaxel in patients with metastatic breast cancerClin Cancer Res200283360812429622
- HendersonTAFischerVWEffects of methylphenidate (Ritalin) on mammalian myocardial ultrastructureAm J Cardiovasc Pathol1995568788838158
- KnepperSMGrunewaldGLRutledgeCOInhibition of norepinephrine transport into synaptic vesicles by amphetamine analogsJ Pharmacol Exp Ther1988247487943263494
- LangeRAHillisLDCardiovascular complications of cocaine useN Engl J Med2001345351811484693
- MadsenSLegemidler mot ADHD og risiko for hjertesykdom2006Norwegian Medicines Agency [online] Accessed on Nov 4, 2007. URL: http://www.slk.no/templates/InterPage____30193.aspx
- McGavockJMVictorRGUngerRHAdiposity of the Heart*, RevisitedAnn Intern Med20061445172416585666
- NissenSEADHD drugs and cardiovascular riskN Engl J Med20063541445816549404
- SchifferWKVolkowNDFowlerJSTherapeutic doses of amphetamine or methylphenidate differentially increase synaptic and extracellular dopamineSynapse2006592435116385551
- SeidmanJGSeidmanCThe genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigmsCell20011045576711239412
- SinghKXiaoLRemondinoAAdrenergic regulation of cardiac myocyte apoptosisJ Cell Physiol20011892576511748583
- TollofsrudCHoelTA young man with acute dilated cardiomyopathyTidsskr Nor Laegeforen20061261338916715575